0000939767-20-000101.txt : 20200529
0000939767-20-000101.hdr.sgml : 20200529
20200529213644
ACCESSION NUMBER: 0000939767-20-000101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200529
FILED AS OF DATE: 20200529
DATE AS OF CHANGE: 20200529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 20930759
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_159080258594506.xml
FORM 4
X0306
4
2020-05-29
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
1
0
0
President and CEO
Common Stock
2020-05-19
5
G
0
E
35935
0
D
85985
D
Common Stock
2020-05-19
5
G
0
E
35935
0
A
889574
I
By Trust
Common Stock
2020-05-29
4
M
0
100000
6.21
A
185985
D
Common Stock
2020-05-29
4
F
0
64550
24.71
D
121435
D
Common Stock
17728
I
By 401(k)
Option (right to buy)
6.21
2020-05-29
4
M
0
100000
0
D
2016-09-16
2022-09-15
Common Stock
100000.0
300000
D
On May 19, 2020, the Reporting Person gifted 35,935 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.
Includes 85,985 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,450 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,550 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 29, 2020 of $24.71.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 28, 2020.
The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-05-29